After 72 weeks of treatment, participants taking tirzepatide lost 20.2% of their body weight (about 50.3 pounds), while those taking semaglutide lost 13.7% (about 33.1 pounds) of their body weight
Research consistently shows that people who prioritize protein on GLP-1 medications lose more fat and less muscle than those who do not
Hence, DMRS has strong potential and feasibility for in vivo metabolic imaging
Virtual visits : Available from home in all 50 states (because leaving the house with a newborn is hard) In-person clinics: Boston area, Chicago, Dallas/Fort Worth, Atlanta area Insurance accepted: Most major plans offer coverage
Aim for 25 to 35 grams daily from food sources like vegetables, fruits, legumes, and whole grains, supplemented as needed
Disclosures: The authors have no conflicts of interest relevant to this article